WR
Watson Rebecca Portfolio holdings
AUM
$170M
This Quarter Return
+12.77%
1 Year Return
+9.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$167M
AUM Growth
+$22.7M
(+16%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
8.65%
Top 10 Holdings %
Top 10 Hldgs %
59.38%
Holding
389
New
308
Increased
27
Reduced
25
Closed
3
Top Buys
| 1 |
iShares US Medical Devices ETF
IHI
|
$3.17M |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.99M |
| 3 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
$1.41M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$1.05M |
| 5 |
iShares Core S&P US Growth ETF
IUSG
|
$902K |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
$2.04M |
| 2 |
Fidelity MSCI Real Estate Index ETF
FREL
|
$1.71M |
| 3 |
Fidelity Low Duration Bond Factor ETF
FLDR
|
$1.3M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
$1.11M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
$928K |
Sector Composition
| 1 | Technology | 4.76% |
| 2 | Communication Services | 4% |
| 3 | Industrials | 3.19% |
| 4 | Healthcare | 2.72% |
| 5 | Financials | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Clarivate
CLVT
$2.79B
| – | – |
0
| – | – |
|
377
Conduent
CNDT
$444M
| $0 | ﹤0.01% |
+40
| New | – |
|
|
CRON
378
Cronos Group
CRON
$969M
| $0 | ﹤0.01% |
+24
| New | – |
|
|
379
Fidelity Low Duration Bond Factor ETF
FLDR
$999M
| – | – |
-25,968
| Closed | -$1.3M |
|
|
380
Fidelity MSCI Real Estate Index ETF
FREL
$1.04B
| – | – |
-77,634
| Closed | -$1.71M |
|
381
iShares US Healthcare Providers ETF
IHF
$795M
| – | – |
-5,815
| Closed | -$219K |
|
382
Levi Strauss
LEVI
$8.91B
| $0 | ﹤0.01% |
+35
| New | – |
|
383
Mercury Systems
MRCY
$4.04B
| – | – |
0
| – | – |
|
384
ON Semiconductor
ON
$19.5B
| $0 | ﹤0.01% |
+10
| New | – |
|
385
Tilray
TLRY
$1.31B
| $0 | ﹤0.01% |
+5
| New | – |
|
386
Wabtec
WAB
$32.7B
| $0 | ﹤0.01% |
+7
| New | – |
|
|
TUP
387
DELISTED
Tupperware Brands Corporation
TUP
| $0 | ﹤0.01% |
+42
| New | – |
|
|
NM
388
DELISTED
Navios Maritime Holdings Inc.
NM
| $0 | ﹤0.01% |
+18
| New | – |
|
|
BMY.RT
389
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $0 | ﹤0.01% |
+115
| New | – |
|